Aditya Birla Sun Life AMC Limited (BOM:543374)
India · Delayed Price · Currency is INR 846.40
-8.40 (-0.98%)
At close: Aug 8, 2025
Inozyme Pharma Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2021 |
Net Income | - | 9,306 | 7,804 | 5,964 | 6,728 | 5,263 | Upgrade |
Depreciation & Amortization | - | 325.1 | 285.7 | 277.2 | 280.35 | 308.58 | Upgrade |
Other Amortization | - | 73 | 60.3 | 66 | 75.84 | 65.85 | Upgrade |
Loss (Gain) From Sale of Assets | - | - | -0.4 | -1.4 | 1.28 | 0.7 | Upgrade |
Loss (Gain) From Sale of Investments | - | -2,584 | -2,591 | -1,071 | -980.06 | -1,231 | Upgrade |
Stock-Based Compensation | - | 57.9 | 232.1 | 311.6 | 482.82 | - | Upgrade |
Other Operating Activities | - | -126.7 | 246.9 | 119.6 | -218.29 | 102.3 | Upgrade |
Change in Accounts Receivable | - | -171.4 | -162 | 16.3 | 47.94 | 95.11 | Upgrade |
Change in Accounts Payable | - | 104.9 | 94.3 | 177.9 | -69.79 | -100.18 | Upgrade |
Change in Other Net Operating Assets | - | 100.2 | 879.2 | -1,487 | -716.02 | 618.55 | Upgrade |
Operating Cash Flow | - | 7,085 | 6,848 | 4,374 | 5,632 | 5,123 | Upgrade |
Operating Cash Flow Growth | - | 3.45% | 56.58% | -22.34% | 9.94% | 3.07% | Upgrade |
Capital Expenditures | - | -312.8 | -306.1 | -189.9 | -163.82 | -115.42 | Upgrade |
Sale of Property, Plant & Equipment | - | 10.2 | 5.3 | 3.4 | 3.9 | 8.68 | Upgrade |
Investment in Securities | - | -3,083 | -4,976 | -1,292 | -2,940 | -3,377 | Upgrade |
Other Investing Activities | - | 335.3 | 169.1 | 135 | 115.23 | 85.78 | Upgrade |
Investing Cash Flow | - | -3,050 | -5,107 | -1,343 | -2,985 | -3,398 | Upgrade |
Long-Term Debt Repaid | - | -150.8 | -118.1 | -182.9 | -192.74 | -169.41 | Upgrade |
Net Debt Issued (Repaid) | - | -150.8 | -118.1 | -182.9 | -192.74 | -169.41 | Upgrade |
Issuance of Common Stock | - | 107.6 | 0.5 | - | - | - | Upgrade |
Common Dividends Paid | - | -3,889 | -1,512 | -3,125 | -2,318 | -1,400 | Upgrade |
Other Financing Activities | - | -56.6 | -56.3 | -39 | -48.63 | -55.57 | Upgrade |
Financing Cash Flow | - | -3,989 | -1,686 | -3,347 | -2,560 | -1,625 | Upgrade |
Miscellaneous Cash Flow Adjustments | - | - | - | - | - | -0 | Upgrade |
Net Cash Flow | - | 45.8 | 54.9 | -316.3 | 87.17 | 99.25 | Upgrade |
Free Cash Flow | - | 6,772 | 6,542 | 4,184 | 5,468 | 5,007 | Upgrade |
Free Cash Flow Growth | - | 3.51% | 56.38% | -23.49% | 9.21% | 4.18% | Upgrade |
Free Cash Flow Margin | - | 34.16% | 39.98% | 31.00% | 38.91% | 41.65% | Upgrade |
Free Cash Flow Per Share | - | 23.42 | 22.66 | 14.49 | 18.93 | 17.39 | Upgrade |
Cash Interest Paid | - | 56.6 | 56.3 | 39 | 48.63 | 55.57 | Upgrade |
Cash Income Tax Paid | - | 2,947 | 1,839 | 1,796 | 2,337 | 1,510 | Upgrade |
Levered Free Cash Flow | - | 7,992 | 7,137 | 5,100 | 5,230 | 5,482 | Upgrade |
Unlevered Free Cash Flow | - | 8,028 | 7,172 | 5,125 | 5,261 | 5,516 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.